808
www.klinickafarmakologie.cz340804001076513320121425327329234035839843647950254457164568672477179183988990895196610061045
/26478040010732
Klin272480400107446583131
Farmakol2870804001074279105180220258306325
Farm.3211804001074178104179195
2026;40(3):153-1573421804001074487128171186230275299342363377415452494521560598640
/41068040010731
KLINICKÁ4183804001074588109168189243289347
FARMAKOLOGIE4547804001074191138210265311372414474533554597
A51618040010753
FARMACIE5231804001074291138210265317337380
15756558020012657110165
HLAVNÍ4945200012671127198263336370
TÉMA5337200012657114204274
Glifloziny42533600106376886116148187218236277314
v4583360010636
léčbě46353600106296196132164
diabetu48153600106375595130163196237
a5068360010638
jeho51223600106225495136
komplikací527436001063372126161191209245287320337
daného34362001095194144190241291
protektivního65962001095181131160205248281302346396418469519
účinku120362001095091112162204255
SGLT-21483620010944102146185209252
inh.176062001092171121140
na192562001095094
vznik34376001094384134155198
či56076001094061
progresi64076001095181131182212257293314
diabetické97376001095172116167213244265306348392
neuropatie.138476001095096146176225277321351372417436
Shrnutí3431010014762131174243312354385
SGLT-24831180010946107154196222267
inh.791118001092175128149
představují981118001095285133188226259307352405429453
skupinu1474118001093782135190214267320
léčiv1834118001092270115138185
s3431320010936
pleiotropními403132001095173119141190220250299351402423498520
účinky947132001095091111162204250
významně1221132001094389130180224299349395
přesahujícími1641132001095181126162206256306328349343146001094061136157
efekt516146001094572117160192
na724146001095094
samotnou834146001093579154204234284333383
kompenzaci1233146001094291166217263314352397438459
diabetu.1708146001095071115166212242292311
Léčba343160001094288129180225
SGLT-25871600010945103146185210252
inh.859160001092171121140
tak1019160001093074116
vedle1155160001094388140161207
změn13821600010938113159210
v16111600010944
hemodynamice,1674160001095096171222273317343174001095195171193234279298
jako667174001092266110159
je852174001092269
snížení947174001093686108148194245267
intraglomerulárního1240174001092172102132177229250301378425455506528572602654675728779
tlaku34318800109305195137187
a5501880010943
obnovení6131880010949101151201244289339360
tubuloglomerulární993188001093079131181203253304325375451497527577599642672722743
zpětné1756188001093890136167217263
vazby,213862001094387127178221235
významně239062001094389130180224299349395
ovlivňuje280162001094992114135179230279301346
zánětlivé316462001093883133179209231252296340
signální352062001093657108158201223273294
dráhy213876001095283128180223
(AMPK,238776001092783158208258280
SIRT1,269476001094668118166212228
NF-κB),2948760010961107136183234259277
čímž325276001094163141181
přispívají346076001095284106143195218263309332354
k2138900010942
antifibrotickému219690001094494123144171195246276326356377417459504579629
a2841900010944
cytoprotektivnímu290190001094085118167219249298328373416448469513564585660710
efektu.362790001094572118161213810400109308099
Uvedené22551040010958102146198244294340
účinky2613104001095091112162204250
na2881104001095093
více2992104001094466106151
úrovních3161104001094979128171222243284334
spojené3513104001093587137159205255301
s21381180010936
léčbou2201118001092269111164216268
touto2496118001093080132163214
skupinou2736118001093780132185207259310362
léčiv3125118001092168111133178
byly3330118001095295119163
ostatně3519118001095188120165196248295
zohledněny2138132001093989141163209262313360411453
v26171320010944
aktuálních2687132001094487120171215237288310351402
doporučeních31151320010951102155207237288330375426448489540
pro3681132001095283133
léčbu2138146001092167108160210
dle2367146001095173118
ADA/EASD,25051460010955115168202247303349408425
kdy2950146001094292135
SGLT-231051460010944102146185209252
inh.3376146001092171122141
jsou3537146001092157107157
indikovány37141460010921712138160001095172114163206250300341
jako2501160001092265108157
nefro-2679160001095096123154203234
a29351600010943
kardioprotektivní3000160001094287116167188238290320369399444487519541584635656
léčba36781600010922671092138174001095195
zcela2255174001093879123145189
nezávisle2465174001095096135181223245280301347
na2833174001095094
dosažené29481740010951101137181221266316362
kontrole3331174001094391142171201251273318
glykemie36711740010950711142138188001094287162184229
(14).2386188001092567109133150
Recentní2554188001094994136180231260311332
data2904188001095194124168
z30911880010938
experimentálních3148188001094588140186216238313359409439483504554575616666
studií393462001093565113163184204
naznačují415362001094991130179221260309329350
potenciální4518620010950100128172221261281323344392413
protektivní494562001095180128157200242274294337386406
účinek536662001094989109158202244
v3934760010943
oblasti3999760010949101123167202233254
diabetické427476001095172116167214244265306348392
retinopatie468876001092974105126176226278322352373418
a5128760010943
neuropatie519376001094995145175224276320350371417
i3934900010921
možné3969900010973122159207252
přínosy42359000109507999148196230273
v4522900010942
léčbě457990001092065105154199
neurodegenerativních479290001094993142170218268312362406455499528570599619661710730770818
onemocnění.3934104001094999144219269310359404454475494
Budeme4443104001094998149194269315
muset47731040010975124159205235
zřejmě5023104001093968113134209254
ještě5293104001092167102132177
několik54851040010950953934118001094291113134176
let412911800109216797
čekat4245118001094084127172202
na4465118001095094
data4577118001095194124168
získaná476411800109386095137182232275
dle5058118001095172118
požadavků51941180010952102141186237281323366416
Evidence-Based3934132001094486107158203253293337367417460495540592
Medicine45411320010972117169189229250299344
(EBM),4901132001092568116188212229
než5145132001095095133
budeme52941320010951100151196271316
moci39341460010974122162182
konstatovat,4131146001094289138172202245273321362405433452
že4598146001093781
SGLT-246941460010944100142180204245
inh.4953146001092170118137
mají51041460010974116137158
rozšířeny5276146001092977114150170201245294334
své3934160001093682128
indikace.4089160001092273126149192238281326346
Ale4462160001095678126
experimentální4614160001094691144192223246323371423453499522573595
data5236160001095297128173
nám5436160001095196174
ukazují,3934174001095092137176226248269288
že4238174001093984
možnost43391740010975125163214264299330
dalšího4686174001095194116151172224274
rozšíření4977174001092978116154175207252303324
indikací5317174001092172123144186231272293
v39341880010943
budoucnu39961880010952102153203253294344394
pro4409188001095181131
SGLT-245591880010944102146185209252
inh.4830188001092171121140
není4990188001094995146167
nereálná.5176188001095096126171214236286329349
LITERATURA344211001234978134189250318368438498567
1.34322800853648
Kirk4072280083355172103
EP,5262280083326872
Klein6142280083355286102139
S.76922800833346
Pathogenesis8312280083356788127165205239277312339354380
and122722800833270109
pathophysiology13522280083387193131170209248278305320358374412452484
of185222800833756
the19242280083226095
cardiometabolic3432380083326586125141179238274296330369409425440473
syndrome.8372380083265998138160197256292304
J1162238008325
Clin12082380083405571109
Hypertens133823800834577117153175200234273300
(Greenwich).16592380083186284118154193244260292331349360
2009;11(12):761-765.34324800833468104140152182210225257287305317350382412431462494528540
2.34325800853550
Shulman40525800833269105120176208245
GI.6622580083435870
Cellular7442580083397287102138153184205
mechanisms96125800835690122159190227242267323349
of132225800833655
insulin13892580083145177113128142179
resistance.1580258008320537993119141173210241274285
J1877258008324
Clin19132580083395468105
Invest.3432680083155384118145168182
2000;106(2):171-176.54026800833468104141153184215251270304322333363393425444475504536549
3.34327800853652
Redfield41627800833672112130148183199239
MM,676278008355111125
Borlaug8222780083367598114147185225
BA.10682780083367893
Heart118227800834580113135160
Failure1363278008333637994133154189
With15732780083587598137
Preserved17312780083365792119155177212247288
Ejection3432880083334882115139155193231
Fraction:5892880083335285118142157195233245
A850288008341
Review.90628800833570103118153204215
JAMA.113628800832565120162177
2023;329(10):827-838.132828800833468101136147182215249268300331350362396430463482517551586599
4.34329800853651
Gong40829800834482121160
Q,58229800834761
Zhang65729800833876108146185
R,85629800833650
Wei92029800835791106
F,104029800833238
et109329800833456
al.11632980083324760
SGLT2123829800833276109138173
inhibitor-empagliflozin142629800831452901051441601822192412612973553944274664814965145315693433080083284482
treatment4413080083224377109131189224262283
ameliorates74130800833189124140155193214247269303330
diabetic10873080083385385124160182197229
retinopathy1333308008320547792130168208241262301331
manifestations16803080083589012814316219722424728030131734331800833776102
and46231800833270109
exerts5893180083346599120145173
protective7793180083396098120153186210225258292
effects10893180083345372107139163191
associated12973180083325985124156171203225259298
with16133180083506688127
augmenting1757318008332691081662012393433280083213674112
branched4683280083385992129161199233272
chain75332800833168100115152
amino91832800833188103141178
acids11093280083316378116142
catabolism12643280083316384117156194209224250307
and158332800833269108
transportation170332800832243751131391772162372612943433380083223775113
in47233800831452
db/db54033800833877102137176
mice.73233800835772104138150
Biomed8973380083365189147182222
Pharmacother.113433800833573105126185217249286308346381402413
2022;152:113222.156233800833468101136148178208242254284312342374409444456
5.34334800853549
Zinman4043480083375289145177214
B,63034800833547
Wanner68934800835687124161195215
C,91634800834052
Lachin9803480083316495132146183
JM,11753480083247891
et127834800833355
al.13453480083314658
Empagliflozin,141534800833289127159197212226243260297324339376388
Cardiovascular181534800834072921291441813433580083326491123161176208229
Outcomes,58535800834786108139176234269296309
and90735800833169108
Mortality102835800835593115139172187202225258
in129935800831553
Type136535800833260100135
21513358008334
Diabetes.15603580083466193132168190224250264
N1837358008345
Engl189535800833270109124
J343368008324
Med.38236800835590130143
2015;373(22):2117-2128.54036800833468100130141176208242260294329347359394425453482501532563593627640
6.34337800853652
Kovesdy41337800833572104139165205237
CP.6683780083407681
Epidemiology7683780083327187126161219234272288326365397
of118437800833757
chronic12603780083316990127166181213
kidney14923780083294685123158189
disease:17003780083385379114146173208220
An193937800834179
update34338800833776116148170204
2022.56238800833468101136148
Kidney7263880083355190128163194
Int9363880083155274
Suppl.102538800833370109149165178
2022;12:7-11.121838800833468101136148178208221254273304331341
7.34339800853543
Gajewska3983980083437489122172198227259
A,66939800834053
Wasiak73439800835686112126157186
J,93139800832435
Sapeda97839800833263101136174205
N,119539800834356
et126239800833355
al.13283980083314658
SGLT2139839800833274105133168
Inhibitors15773980083155288103140155177212233259
in184839800831451
Kidney1910398008335508834340800833771102
Diseases-A4574080083445985119150176210236256297
Narrative7664080083447596117149170185216250
Review.102840800833569100115149199210
Int12504080083145172
J1334408008324
Mol137040800835491107
Sci.1489408008332637890
2024;25(9):4959.15914080083346799130141176210227258276287321353386418428
8.34341800853652
The41541800833372107
EMPA-KIDNEY54241800833388124161183220236282328361398
Collaborative9604180083407793108140180219240273295310343377
Group,135841800834365102140180192
Herrington157041800834479100122138176215238275313
WG,1903418008358102115
Staplin3434280083335589130146162201
N,56642800834559
Wanner64742800835891130169206228
C,89642800834155
et97242800833558
al.10524280083324862
Empagliflozin113542800833493134168208224240259276315345361400
in155742800831554
Patients16324280083366992108144183206234
with18884280083526891131
Chronic3434380083407899136175190222
Kidney5804380083355190128163195
Disease.7904380083456187122154180215227
N1033438008344
Engl109343800833270109125
J1233438008324
Med.127243800835590129143
2023;388(2):117-127.143043800833468101136147182217252271305323335364392422440471501534540
9.34344800853649
Verma4114480083366890148180
A,61044800834155
Patel6844480083356789123138
AB,8414480083417790
Upadhyay95044800834482115154192223256287
A,125644800834155
et133044800833456
al.14054480083324760
CREDENCE:148444800834075109154188233273306319
Significant1822448008333488612413915717434345800833164102124
Victory4844580083355284108145166200
for7014580083185678
Diabetic7964580083456092132167189205237
Kidney10504580083345190128163194
Disease.12614580083456187122154180215228
Trends15064580083324983121161187
Endocrinol171045800833270109147180201217255293309
Metab.34346800835490112145184196
2020;31(6):391-393.55546800833468101135148183214229262280292327360392411444477510522
10.3434780085366983
Heerspink43847800834478113134160198214251280
HJL,7314780083436899113
Jongs8564780083246199137163
N,103147800834557
Chertow110047800834077111132156193243
GM,135547800834397110
et147847800833355
al.15454780083324759
Effect16174780083325069103135158
of178847800833755
dapagliflozin185647800833769108140343488008338536886103141169185223
on58048800833775
the6694880083226095
rate7784880083215476109
of90148800833857
decline97248800833873106121136174209
in119548800831452
kidney12614880083304685123158190
function14654880083185795127151166204243
in172248800831452
patients17884880083397294109144182203231
with3434980083516689127
chronic4844980083316990128166181213
kidney7124980083294584122157189
disease9154980083385380115146173208
with11374980083516689127
and127849800833270109
without14024980083506688126165203225
type16424980083215595131
21787498008334
diabetes:18354980083395486125160343508008322558295
a455508008331
prespecified5035080083396094121160196228244261278313353
analysis87250800833270102118150177191218
from11065080083194178136
the12595080083226095
DAPA-CKD137150800834585120158179222257304
trial.1692508008322435991106119
Lancet182850800833164103135168191
Diabetes21382280083456193133168191225252
Endocrinol.241022800833371110149181203219257295311324
2021;9(11):743-754.275522800833468101133141177196228256270282316346379401433465501513
Erratum32892280083335476109131169227
in:35372280083145264
Lancet362222800833265103136170192
Diabetes21382380083456193132168190224250
Endocrinol.240423800833270109147180201217255293309322
2022;10(10):e10.274123800833469101136149179210230261293311323358387419431
11.21382480085366678
Heerspink223624800834479115136163202218255286
HJL,254124800834469101115
Perco26752480083356889121157
P,285124800833640
Mulder291024800835593108147182203
S,313224800833245
et319624800833457
al.32722480083314760
Canagliflozin335124800834072111143182197212230247285313329367
reduces373724800832054213825800833875107140167
inflammation2318258008314526986118175233265287302339378
and270825800833270108
fibrosis2829258008317347294131157172198
biomarkers:30402580083385391149181202232266287314327
A3379258008341
potential34332580083387798132170191206238253
mechanism369925800835792213826800833169102140155181238
of239626800833757
action24722680083326488104142180
for26722680083185677
beneficial276926800833974112147165182214229261276
effects30652680083345473107140164191
of327626800833757
SGLT2335226800833377109138174
inhibitors35452680083155391106145161183220242269
in213827800831553
diabetic22062780083385385124160182197229
kidney24512780083294685123158189
disease.26552780083395480115147173208220
Diabetologia.28912780083456193132167190227242281320335367381
2019;62:1154-1166.328727800833468100130143179212225254282312347370401429460495509
12.21382880085366782
Santulli223328800833265102123160175190205
G,245028800834356
Varzideh25192880083356686116132170204242
F,277328800833238
Forzano28232880083326990120153191228
I,306428800831427
et310328800833456
al.31712880083314659
Functional324228800833268106137161176213251283298
and355228800833269107
Clinical3672288008339546910612121382980083316378
Importance222829800831572110148169193226263294327
of256829800833755
SGLT2-Inhibitors263629800833275107135170190206243281295334349371407428455
in310329800831451
Frailty:3167298008332518398113135168181
From33602980083325188145
the35172980083225993
Kidney36232980083345088126160191
to213830800832259
the22123080083226095
Heart.232230800834479111132157170
Hypertension.250730800834576116152173198231270296311349387400
2023;80:1800-1809.292330800833468101136147182218231260291327363387418449484519530
13.21383180085366782
Vallon2233318008335668196133171
V,241631800833644
Thomson247331800833271108166192229267
SC.27533180083327285
Targeting28503180083326080118152174189226265
renal31273180083215492123138
glucose32783180083385289121157183218
reabsorption35083180083215486124150188209248270285213832800833776
to222732800832258
treat22993280083214377109130
hyperglycaemia:244332800833768108143165203218250281314349407422454466
The292332800833271106
pleiotropic30433280083385489104142164185223262278310
effects33663280083345473107140164191
of357132800833756
SGLT2364032800833377109138174
inhibition.21383380083155391106145160183198236274288
Diabetologia.24413380083456193132168190227243281320336368381
2017;60:215-225.283733800833468100130139175211224259290320342373408443455
14.21383480085377188
American2248348008342102139161178211246285
Diabetes25553480083476397138175198233261
Association283834800834372100139174190223246262302342
Professional32023480083365897117153181209225264304338354
Practice35783480083365893126152168201236
Committee213835800834077135193208231255289324
for24833580083185678
Diabetes.25813580083456193132168190224251264
Summary286635800833270128185218239273
of316035800833756
Revisions:323735800833570102118144159197236262274
Standards35323580083325386124164196217255282
of213836800833757
Care22123680083407394128
in235836800831452
Diabetes-2026.24283680083456193132168190224250271302336369403416
Diabetes28623680083456193132167190224250
Care.31303680083407394128140
2026;49(1328836800833468101135147182215234265
Suppl357136800833370109149165
1):37533680083344961
S6-S12.21383780083326891122153183196
15.21383880085366883
Gohari223638800834482121153174190
S,244038800833345
Ismail-Beigi25003880083144198131146161183220255271309325
F,283938800833238
Mahjani289138800835587125140172210226
M,313138800835468
et321338800833456
al.32833880083324760
The335838800833271106
effect34793880083345372107139163
of365738800833756
sodium-glucose37273880083266521383980083385391149171212227264296333360395
co-transporter25523980083316891113135168206232271310332356390411
22982398008334
(SGLT2)30343980083195095127156192209
inhibitors32623980083155290106145160183220241268
on354939800833776
blood36433980083395493131171
interleukin-621384080083155375109131147182221251268306329367
concentration:252640800833169108140174213235257290312328366405418
A2965408008341
systematic30274080083265987110144203236258274306
review33544080083215588104139191
and356640800833271110
meta-analysis36974080083589321384180083225477109147179195227254268295
of245141800833756
randomized25254180083215492131169227243272306345
controlled288841800833268107128150187203218253292
trials.3199418008321435890106132145
BMC336241800833691131
Endocr351141800833371110148181202
Disord.37314180083456121384280083266486124137
2023;23:257.229142800833468101135147182217228263298331338
16.21384380085366985
Schönberger223743800833265103141180219254275314348370
E,262043800833346
Mihaljević267943800835470108140155171205238253285
V,297743800833645
Steiner30354380083335487103140175197
K,324543800833549
et330843800833456
al.33774380083324760
Immunomodulatory34504380083157313116820624530334121384480083387692124146183205239
Effects23984480083335271106139163191
of260944800833857
SGLT2268744800833377110139175
Inhibitors28824480083155492107146162185222244271
–3174448008335
Targeting32304480083336182120156178194232271
Inflammation352244800831553718812017823626921384580083223775113
and227145800833270109
Oxidative24004580083477995133166187203235270
Stress26904580083325375109136162
in287245800831553
Aging.29454580083417994132171184
Int31494580083155375
J3244458008324
Environ328845800833370102117138176214
Res35224580083367197
Public364045800833572111127142174
Health.213846800834479111126149187200
2023;20:6671.235346800833569102136148183217230265301334366376
17.21384780085366876
Antonetti223347800834179101138176211233258273
DA,25244780083458599
Barber26404780083366990130165186
AJ,28444780083416880
Bronson29424780083355694132158197235
SK,31954780083326781
et329447800833456
al.33684780083324760
Diabetic34464780083456092132167190205237
retinopathy:3700478008321557793213848800833876115148170208239252
seeing24034880083276297112150189
beyond260548800833974106143182221
glucose-induced28394880083385391123160186221245261298337375407441480
microvascular333248800835873105126163195228255287325340372393
disease.37384880083385421384980083266193120155167
Diabetes.23204980083456193132168190224251264
2006;55(9):2401-2411.259949800833569105141153188220238271289300336368403435454485517547575584
18.21385080085366985
Villarroel,2244508008336526782115136158195231246259
García-Ramírez25235080083447698129144176198235268326341362396426
M,296950800835568
Corraliza30585080083407798120153168183213246
L,332450800833246
et339050800833456
al.34675080083314760
Effects35475080083335271105138162190
of375750800833757
high39342280083385391129
glucose40792280083385390123160186221
concentration431522800833269107139173211233254287309324362400
on473122800833775
the48212280083226095
barrier49312280083397293115131165187
function51332280083185795127151166204243
and539122800833270109
the55152280083226095
expression393423800833465105127161187214229267305
of425923800833757
tight43362380083213675113135
junction44912380083155290122146162200238
proteins47492380083396097119153168206232
in500123800831553
human507423800833775132165203
retinal5297238008320547792130162177
pigment54942380083395493393424800835792130152
epithelial41012480083347489112150185200215247263
cells.4379248008331658196122135
Exp453024800833265104
Eye46502480083326397
Res.47632480083357097111
2009;89(6):913-920.488924800833468104139152188222241274292304339371401423458491525538
19.39342580085366982
Hammes403325800834476134192227254
HP.43042580083447985
Diabetic44052580083466193132168190205237
retinopathy:4659258008321557792130169208241263301332345
hyperglycaemia,502125800833768108144165203218250281314349407422454467
oxidative5505258008337678339342680083387092107140174
stress41242680083264970104131158
and429726800833270109
beyond.442126800833974106144182221234
Diabetologia.46712680083456092132167189226242280320335367380
2018;61(1):29-38.506726800833468100131143179209224256270282317351375407442455
20.39342780085367287
Kostrzewska40392780083357299122144174208260287316350
P,440727800833540
Kuca446527800833472104137
P,462027800833539
Witek46772780083587496130160
P,485527800833540
et491327800833456
al.49872780083324760
SGLT-2506527800833377109138157188
Inhibitors52712780083145290105144160182219241268
in555727800831553
the39342880083226096
Prevention40502880083355691123158196218233272310
and438128800833270110
Progression45112880083365794134155190217244259297336
of486728800833857
Neurodegenerative494528800834580118139177217252292327365401422455477493526560
Diseases:55262880083456139342980083266092118152179191
A4137298008341
Narrative41902980083457697118151172187219253
Review.445529800833570102117151202212
Neurol468029800834478116136173189
Ther.488129800833271105126136
2025;14(6):2295-2312.503029800833467100134144174205224256274286320354388422443474508538568580
21.39343080085377387
Braffett40463080083366095117136173197223
BH,42943080083378499
Gubitosi-Klug441830800834586127145169208237254278317335375417
RA,48603080083368298
Albers498330800834259101139162191
JW,51993080083258798
et532230800833559
al.54063080083335065
Risk54963080083365382114
Factors39343180083336498124163186215
for41723180083185881
Diabetic42763180083466397138176199216250
Peripheral45493180083367194111152192229252286303
Neuropathy487531800834683122145184226260284324356
and525431800833373114
Cardiovascular5390318008341769813915519539343280083326693127166182215237
Autonomic419432800834179103141180220279295328
Neuropathy454532800834581120142180221255278317349
in491632800831554
the49923280083226197
Diabetes51113280083466295136172196231258
Control539232800834078118140163201218
and393433800833271112
Complications406833800834078138179195211245279301318357397424
Trial/Epidemiology45143380083335268101118145180220236276312372388427444483524557
of509433800833758
Diabetes51743380083466295136173196231259
Interventions54553380083155477112134393434800833267105128144182221248
and420034800833271111
Complications432834800834078137177193209242275298314352392419
(DCCT/EDIC)476434800831965107146183205239286302344365
Study.51463480083335593133166176
Diabetes.53403480083466294134171194228256270
2020;69(5):1000-1010.393435800833469103137151187222242276295308338370407444469500532565597610
22.39343680085367288
Callaghan40393680083407388103135174212245283
BC,43383680083367689
Cheng444436800834077112151190
HT,46503680083447887
Stables47543680083325386125141176203
CL,49733680083407285
et507536800833456
al.51473680083324861
Diabetic52243680083456193132168190205237
neuropathy:54783680083377211039343780083215897129151189219233
clinical4179378008331466199114145178193
manifestations438537800835789127142161195221244277298313351389415
and481337800833269108
current49343780083316889111145182204
treatments.51503780083224377109130188223260282309323
Lancet54853780083316510239343880083316587
Neurol.403738800834479117138175191204
2012;11(6):521-534.425738800833468100129142172200215248266278313346378397430464499511
23.39343980085367287
Vekic40393980083366899115147
J,420339800832537
Zeljkovic42573980083387187102132170202217249
A,452439800834155
Maggio459639800835587126165180218
V,483239800833544
et489439800833356
al.49673980083324760
Innovative50453980083145290129161194215231263297
Diabetes53603980083456193132167190223250
Therapies393440800833372107128161200216250277
and422640800833270109
Impact435040800831573112145177202
on456740800833775
Peripheral46584080083356889105144183218239272287
and496040800833270109
Autonomic508440800834178101138176215273288320
Diabetic5419408008346619313216839344180083223769
Neuropathies:402241800834580117139176215248270308323358385397
A4438418008341
State-of-the-Art44984180083335487108142165205224245267305340364405426451
Review.496841800833570102118153204215
Diabetes52024180083456193132168190224250
Ther.547141800833372107129139
2026;17(3):331-355.393442800833468101135147177207223257274286321354385403436469501513
24.39344380085367186
El-Haggar40374380083334870116148187226259280
SM,433343800833387101
Hafez44504380083447795130159
YM,462643800833590103
El474643800833348
Sharkawy481043800833370103124155188239273
AM,509943800834197110
et522643800833456
al.52994380083314760
Effect53754380083335271105138162
of555343800833857
empagliflozin393444800833492131164203218233251268306334350388
in433744800831553
peripheral44054480083397596112151189224245278294
diabetic47144480083385486125160183198230
neuropathy496044800833772110131168208241262301331
of530744800833756
patients53794480083397293109143182203231
with39344580083516789128
type40824580083225696132
24234458008335
diabetes42894580083395486126161184218245
mellitus.455545800835792108123139161199226240
Med481545800835590130
Clin49664580083405570108
(Barc).50954580083195588109140159170
2024;163(2):528645800833468102134146176207241260294312324
53-61.39344680083346789126157166
25.39344780085367387
Adhikari404247800834179118133163196218233
U,429647800834455
Gad437147800834477116
H,450747800834457
Chatterjee458547800834078110132156190211227262298
D,490347800834556
et498047800833456
al.50574780083314760
Dapagliflozin513747800834678117150189205220238255293321337375
for55324780083195678
Small393448800833290122138153
Nerve410248800834580101136170
Fibre42884880083324786108142
Regeneration444548800833671110145183218239272294309347386
in484648800831553
Diabetic49144880083456193132168190205237
Peripheral51674880083356890105144183218239272287
Neuropathy:54704880083458011739344980083215897130152190221235
A4187498008341
Randomised424649800833568106145183241256283318357
Controlled462149800834077116137159196212227262301
Study49404980083335492131163
(DINE).51214980083196480125158178189
J5328498008324
Peripher53714980083356889105144183218239
Nerv393450800834580101136
Syst.40855080083326289112126
2025;30(1):e70011.422650800833468101136147182216236268282294328361394430462490499